DalsnaFinance › IPOs › Attovia Therapeutics, Inc. › IPO
Attovia Therapeutics, Inc. completed its initial public offering on Nasdaq on July 29, 2026, pricing at $17.00 a share.
| Ticker | ATTO |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | July 29, 2026 |
| Offering price | $17.00 |
| Sector | Biological Products, (No Diagnostic Substances) |
Attovia Therapeutics, Inc. listed on Nasdaq on 2026-07-29.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 2058707.
Attovia Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Attovia Therapeutics, Inc.. This page is general information, not investment advice.